id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
39,,,,,,,,,,,,,,,2024-05-04T13:41:03+06:00,BSH - H12204245651,,Gemcitabine   Cisplatin,2023-10-18,,"Started NACT with AC on 13.04.2022, C4 CT with AC completed on 19.06.2022. Started Paclitaxl +
Carboplatin on 13.07.2022. Cycle 8 is completed on 20.09.2022
Now on Adjuvant ChT with Oral Capecitabine, C1 started from March 2023, C8 completed on 11.09.2023.
Due to local recc> Palliative ChT with Gemcitabine (D1,D8) q3w C1D1 started 24.09.2023, From C2D1 Inj
Cisplatin added on 18.10.2023, , from C4D8 Inj Trisela added and C6D8 due on 10.03.2024.
Surgery: After NACT> On 25.10.2022, MRM (Right) done at BSHL",,,2024-03-21,,2023-09-23,,,Breast,36,Upper middle class,BSBSC-240000036,MRS. NARGIS AKTER,1718145258,1971-04-12,Female,,,,,Dr Md Arifur Rahman,BSH,3.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.5- Lower-outer quadrant of breast,Breast,Right,,,Stable,Alive,CR,,,,,,,,,,,,,,,,,,,,,
